Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_assertion description "[To describe baseline and emergent HIV-1 resistance to elvitegravir/ cobicistat/emtricitabine/tenofovir DF (EVG/COBI/FTC/TDF) and ritonavir-boosted atazanavir/emtricitabine/tenofovir DF (ATV+RTV+FTC/TDF) in HIV-1-infected, treatment-na�ve subjects through 144 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_assertion evidence source_evidence_literature NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_assertion SIO_000772 25350960 NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_assertion wasDerivedFrom befree-20150227 NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_assertion wasGeneratedBy ECO_0000203 NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP713020.RAiMmJ-f1UrVASO85pyYF6AkGCaTfzSkSOjyLcOC2g2-s130_provenance.